ey0021.15-4 | New Treatments | ESPEYB21
S Osataphan
, M Vamvini
, ED Rosen
, L Pei
, N Erlikh
, G Singh
, P Dhorajiya
, JA Parker
, JM Dreyfuss
, A Rattani
, ME. Patti
In Brief: This case report describes the successful use of RZ358, a novel human antiinsulin receptor monoclonal antibody therapy, in a patient with severe, refractory hypoglycaemia due to metastatic insulinoma.The tumour and resulting severe hypoglycaemia had been resistant to treatments with octreotide, lutetium Lu 177 dotatate radionuclide, diazoxide, everolimus, dexamethasone, pasireotide, and glucagon and the patient, a 55-year old man w...